Loading company…
Biomedical company developing high-throughput mass spectrometry for metabolomics and proteomics-based diagnostic tests.
Qlife Lab was established in 2016 and is a biomedical company that develops high-throughput mass spectrometry technology for early disease prevention and intervention. Its CEO and founder, Dr. Xiaoliang Cheng, previously served at LBNL (Lawrence Berkeley National Laboratory). The company launched the Qlife Lab 9000 clinical mass spectrometer in 2020 and offers third-party medical testing and in vitro diagnostic reagents. Its Series B funding is planned for clinical mass spectrometry equipment, diagnostic reagents, and workshop and laboratory expansion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in